@pituitarysociety.bsky.social
📤 32
📥 22
📝 2
reposted by
The Lancet Diabetes & Endocrinology
26 days ago
Prolactinomas are the most prevalent functional pituitary adenomas and can result in a proliferative endocrine disorder that is typically highly responsive to medical therapy
www.thelancet.com/journals/lan...
#prolactinomas
#hyperprolactinaemia
#pituitary
#adenomas
#MedSky
#EndoSky
#OncSky
0
0
1
reposted by
Endocrine Society Journals
2 months ago
Clomiphene Citrate in Men With Hypogonadism—Do we Need to Monitor IGF-1 in All Patients?. Read more in
#JES
:
bit.ly/4pU09UK
#SERMs
#IGF-1
#ClomipheneCitrate
@endocrinesociety.bsky.social
loading . . .
Clomiphene Citrate in Men With Hypogonadism—Do we Need to Monitor IGF-1 in All Patients?
Selective estrogen receptor modulators (SERMs) emerged as a plausible option for acromegaly treatment due to their estrogen-like effect of reducing insulin
https://bit.ly/4pU09UK
0
0
1
reposted by
The Lancet Diabetes & Endocrinology
2 months ago
Health-care providers should consider
#Addison's
disease as a differential in a wide variety of presentations, and understand the correct interpretation and limitations of widely available cortisol assays
thelancet.com/journals/lan...
#adrenal
insufficiency
#adrenal
crisis
#MedSky
#EndoSky
loading . . .
Clinical features, investigation, and management of Addison's disease
Addison's disease is the manifestation of adrenal glucocorticoid and mineralocorticoid deficiency from T-cell mediated destruction of the adrenal cortex, and is the commonest cause of primary adrenal ...
https://thelancet.com/journals/landia/article/PIIS2213-8587(25)00393-6/fulltext
0
2
1
reposted by
The Lancet Diabetes & Endocrinology
2 months ago
Despite oral corticosteroid replacement therapy, people with
#Addison's
disease have increased mortality in addition to reduced HRQoL and working ability
thelancet.com/journals/lan...
#adrenal
insufficiency
#adrenal
crisis
0
3
2
Free Webinar November 10th ! Register for a discussion of all new and ' cool' in the pituitary arena, clinical and research, new medications in development, new guidelines. Large multidisciplinary international panel led by
@mariafleseriu.bsky.social
&ShlomoMelmed
events.zoom.us/ev/AkPglLvFf...
loading . . .
Pituitary Advances in the Spotlight: 2025 Rapid-Fire Webinar
https://events.zoom.us/ev/AkPglLvFfPL7rsfAY8buTOoDATqaAGMrEpsrOvOyp-ZB4zrnrOgg%7EAtiyzZ0hDF2WfAKqAgcAMS_GW_b7O2mxo2-rHe7XA77ZDeHCHNDSftxHKg
6 months ago
1
0
0
reposted by
European Society of Endocrinology
8 months ago
Delighted to share Commentary from
#Pituitary
, the official journal of
@pituitarysociety.bsky.social
who endorse the newly Revised ESE Guideline👉
ow.ly/JUOc50WCJTJ
@geraldraverot.bsky.social
0
2
2
reposted by
Maria Fleseriu, MD
9 months ago
Happy to share our recent
#consensus
#guideline
on how to multidisciplinary manage
#pituitary
#incidentalomas
; good news on data to recommend less frequent
#imaging
for many microadenomas , but also smaller macroadenomas.
@pituitarysociety.bsky.social
@ohsubrain.bsky.social
@ohsunews.bsky.social
add a skeleton here at some point
0
11
3
reposted by
Niki Karavitaki
about 1 year ago
Thromboprophylaxis in patients with endogenous Cushing's remains a hot topic. Our just released Position Statement is available at DOI: 10.1093/ejendo/lvaf017
0
1
1
you reached the end!!
feeds!
log in